← All Sponsors
SPONSOR

Jazz Pharmaceuticals

Total Trials
3
Recruiting
3
Phases
Phase 3, Phase 1, Phase 2
Conditions studied: H3 K27MGliomaRefractory Ewing SarcomaRelapsed Ewing SarcomaEwing SarcomaLennox Gastaut SyndromeDravet SyndromeTuberous Sclerosis Complex
NCT05580562 Phase 3
Recruiting

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

H3 K27M
United States, Argentina, Australia View Trial →
NCT05734066 Phase 1, Phase 2
Recruiting

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Refractory Ewing Sarcoma
United States, Canada View Trial →
NCT05485831
Recruiting

Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

Lennox Gastaut Syndrome
Italy View Trial →